Low-Income Older Adults’ Vulnerability to Anticholinergic Medication-Associated Frailty-Reference-Cited by-同舟云学术

Low-Income Older Adults’ Vulnerability to Anticholinergic Medication-Associated Frailty

Published:2023-10-19 Issue:12 Volume:40 Page:1123-1131
ISSN:1170-229X
Container-title:Drugs & Aging
language:en
Short-container-title:Drugs Aging

Author:

Sargent Lana^ORCID,Zimmerman Kristin M.,Mohammed Almutairi,Barrett Matthew J.,Nawaz Huma,Wyman-Chick Kathryn,Mackiewicz Marissa,Roman Youssef,Slattum Patricia,Russell Sally,Dixon Dave L.,Lageman Sarah K.,Hobgood Sarah,Thacker Leroy R.,Price Elvin T.

Funder

Center for Healthy Aging Behaviors and Longitudinal Investigations

African American Cardiovascular Pharmacogenetic Consortium (ACCOuNT) study

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Geriatrics and Gerontology

Link

https://link.springer.com/content/pdf/10.1007/s40266-023-01069-7.pdf

Reference38 articles.

1. Hirsch C, Anderson M, Newman A, Kop W, et al. The association of race with frailty: the cardiovascular health study. Ann Epidemiol. 2006;16(7):545–53. https://doi.org/10.1016/j.annepidem.2005.10.003.

2. Morley JE, Malmstrom TK, Miller DK. A simple frailty questionnaire (FRAIL) predicts outcomes in middle aged African Americans. J Nutr Heal Aging. 2012;16(7):601–8. https://doi.org/10.1007/s12603-012-0084-2.

3. Fried LP, Tangen CM, Walston J, Newman AB, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56(3):M146–56.

4. Nishtala PS, Salahudeen MS, Hilmer SN. Anticholinergics: theoretical and clinical overview. Expert Opin Drug Saf. 2016;15(6):753–68. https://doi.org/10.1517/14740338.2016.1165664.

5. Salahudeen MS, Nishtala PS. Examination and estimation of anticholinergic burden: current trends and implications for future research. Drugs Aging. 2016;33(5):305–13. https://doi.org/10.1007/s40266-016-0362-5.